These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 32832397)

  • 1. Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options.
    Ghavimi S; Apfel T; Azimi H; Persaud A; Pyrsopoulos NT
    J Clin Transl Hepatol; 2020 Jun; 8(2):168-176. PubMed ID: 32832397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
    Poon RT; Fan ST; Tsang FH; Wong J
    Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional and systemic therapy for hepatocellular carcinoma.
    Gbolahan OB; Schacht MA; Beckley EW; LaRoche TP; O'Neil BH; Pyko M
    J Gastrointest Oncol; 2017 Apr; 8(2):215-228. PubMed ID: 28480062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.
    Wade R; South E; Anwer S; Sharif-Hurst S; Harden M; Fulbright H; Hodgson R; Dias S; Simmonds M; Rowe I; Thornton P; Eastwood A
    Health Technol Assess; 2023 Dec; 27(29):1-172. PubMed ID: 38149643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immunology of Hepatocellular Carcinoma.
    Lawal G; Xiao Y; Rahnemai-Azar AA; Tsilimigras DI; Kuang M; Bakopoulos A; Pawlik TM
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence.
    Cerreto M; Cardone F; Cerrito L; Stella L; Santopaolo F; Pallozzi M; Gasbarrini A; Ponziani FR
    Curr Oncol; 2023 Sep; 30(10):8774-8792. PubMed ID: 37887533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Status Quo and Development of Immunotherapy for Hepatocellular Carcinoma].
    Wang T; Wang WT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):692-698. PubMed ID: 37248607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
    Mahipal A; Tella SH; Kommalapati A; Lim A; Kim R
    Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31366113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of hepatocellular carcinoma.
    Crissien AM; Frenette C
    Gastroenterol Hepatol (N Y); 2014 Mar; 10(3):153-61. PubMed ID: 24829542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in non-surgical management of primary liver cancer.
    Chen X; Liu HP; Li M; Qiao L
    World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review.
    Osaki Y; Nishikawa H
    Hepatol Res; 2015 Jan; 45(1):59-74. PubMed ID: 24965914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
    Yegin EG; Oymaci E; Karatay E; Coker A
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on the Diagnosis and Management of Hepatocellular Carcinoma.
    Raees A; Kamran M; Özkan H; Jafri W
    Euroasian J Hepatogastroenterol; 2021; 11(1):32-40. PubMed ID: 34316462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for hepatocellular carcinoma: Current status and future perspectives.
    Mandlik DS; Mandlik SK; Choudhary HB
    World J Gastroenterol; 2023 Feb; 29(6):1054-1075. PubMed ID: 36844141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
    Chevallier O; Zhao K; Marinelli B; Yarmohammadi H
    Chin Clin Oncol; 2023 Apr; 12(2):17. PubMed ID: 37081710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma.
    Shi Y; Zhai B
    Gastrointest Tumors; 2016 Oct; 3(2):90-102. PubMed ID: 27904861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma.
    Chami P; Jarnagin W; Abou-Alfa GK; Harding J; Kim N; Lin H; El Homsi M; Crane C; Hajj C
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980634
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.